Antonelli A, Saracino A, Agostini S, Alberti B, Melosi A, Gambuzza C, Avantaggiato G, Baschieri L
Istituto di Clinica Medica II, Università degli Studi di Pisa.
Clin Ter. 1992 Sep;141(9 Pt 2):63-8.
Three patients affected with Graves' ophthalmopathy and pretibial myxoedema have been treated with high dose intravenous immunoglobulins. We have observed in all patients clinical improvement of pretibial myxoedema and a parallel reduction or negativization of the titre of circulating thyroglobulin, microsomal, TSH receptor autoantibodies and of non organ-specific antibodies (antinuclear, anti smooth muscle cells and antimitochondrial autoantibodies). In conclusion the results of this study suggest that intravenous immunoglobulin are effective in the treatment of pretibial myxoedema and probably act by an immunomodulation of autoimmune phenomena.
三名患有格雷夫斯眼病和胫前黏液性水肿的患者接受了大剂量静脉注射免疫球蛋白治疗。我们观察到,所有患者的胫前黏液性水肿均有临床改善,同时循环甲状腺球蛋白、微粒体、促甲状腺激素受体自身抗体以及非器官特异性抗体(抗核抗体、抗平滑肌细胞抗体和抗线粒体自身抗体)的滴度相应降低或转阴。总之,本研究结果表明静脉注射免疫球蛋白对胫前黏液性水肿的治疗有效,其作用可能是通过对自身免疫现象进行免疫调节来实现的。